Skip to main content
Clinical Trials/NCT04379193
NCT04379193
Completed
Not Applicable

Ambulatory Neuroproprioceptive Facilitation and Inhibition Physical Therapy Does Not Modulate Serum Level of Neuroactive Steroids

Charles University, Czech Republic0 sites63 target enrollmentMay 20, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Charles University, Czech Republic
Enrollment
63
Primary Endpoint
serum level of neuroactive steroids
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study describes modulation of neuroproprioceptive facilitation and inhibition physical therapy on serum level of neuroactive steroids in multiple sclerosis.

Detailed Description

In the parallel group, single blind, randomized controlled trial, participant underwent two kinds of neuroproprioceptive PT (MPAT and VRL). At baseline and after the end of the two months' therapeutic program, a blinded assessor evaluated clinical outcomes and data from serum level.

Registry
clinicaltrials.gov
Start Date
May 20, 2015
End Date
September 1, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Charles University, Czech Republic
Responsible Party
Principal Investigator
Principal Investigator

Kamila Řasová

assoc. prof. Kamila Řasová, Ph.D.

Charles University, Czech Republic

Eligibility Criteria

Inclusion Criteria

  • prevailed spastic paraparesis, stable clinical status and treatment in the preceding 3 months determined by neurologist,
  • Expanded Disability Status Scale score (EDSS) max. 7.5

Exclusion Criteria

  • other neurological disease or conditions disabling movement

Outcomes

Primary Outcomes

serum level of neuroactive steroids

Time Frame: 2 months

cortisol, cortisone, 7 alfa-OH-DHEA, 7 beta-OH-DHEA, 7 oxo- oxo-DHEA, DHEA

Secondary Outcomes

  • Berg Balance Scale, BBS outcomes(2 months)
  • Paced Auditory Serial Addition Test(2 months)
  • the 29-item Multiple Sclerosis Impact Scale, MSIS -29(2 months)
  • Modified Fatigue Impact Scale(2 months)

Similar Trials